Unique ID issued by UMIN | UMIN000030703 |
---|---|
Receipt number | R000034915 |
Scientific Title | Assessment of cardiac involvements in rheumatoid arthritis using a cardiac magnetic resonance approach: multicenter prospective study |
Date of disclosure of the study information | 2018/01/12 |
Last modified on | 2021/01/08 15:40:32 |
Assessment of cardiac involvements in rheumatoid arthritis using a cardiac magnetic resonance approach: multicenter prospective study
Assessment of cardiac involvements in rheumatoid arthritis
Assessment of cardiac involvements in rheumatoid arthritis using a cardiac magnetic resonance approach: multicenter prospective study
Assessment of cardiac involvements in rheumatoid arthritis
Japan |
rheumatoid arthritis(RA)
Clinical immunology |
Others
NO
In this study, we will consider the following items using non-invasive cardiac MRI.
to identify the frequency and the extent of cardiac involvement in RA patients who do not have any cardiac disorders
Others
to evaluate the effect of biologics and estimate the improvement of prognosis
We explored the associations of cardiac MRI abnormalities with RA disease activity and severity measures.
We evaluate to detect the influence of Biologics in cardiac function
Observational
20 | years-old | <= |
75 | years-old | >= |
Male and Female
1)All rheumatic disease patients were over twenty years old and met the American College of Rheumatology criteria.
2)Cardiac symptoms were absent in all subjects.
Participants were excluded if they had prior self-reported, physician-diagnosed cardiovascular events or procedures, such as myocardial infarction, angioplasty, and CHF. Additional exclusions were diabetes (HbA1c>6.1), hypertension ((systolic blood pressure (BP) >140 mm Hg and/or diastolic BP>90 mm Hg), and dyslipidemia (LDL cholesterol levels >140 mg/dL, an HDL cholesterol level<40 mg/dL, or a triglyceride level>150 mg/dL).History of bronchoconstriction, contraindication to MRI, hypersensivity to gadolinium were absent in all subjects, and others in which the physician deemed inappropriate to enter the study.
40
1st name | Isamu |
Middle name | |
Last name | Yokoe |
Nihon University School of Medicine
Division of Hematology and Rheumatology
173-8610
30-1 Oyaguchi Itabashi-Ward, Tokyo Japan 173-8610
0339728111
yokoe@po.kyoundo.jp
1st name | Hitomi |
Middle name | |
Last name | Kobayashi |
Nihon University School of Medicine
Division of Hematology and Rheumatology
173-8610
30-1 Oyaguchi Itabashi-Ward, Tokyo Japan 173-8610
0339728111
pero1995@gmail.com
Nihon University School of Medicine
Nihon University School of Medicine
Other
Nihon University School of Medicine
30-1 Oyaguchi Itabashi-Ward, Tokyo Japan 173-8610
0339728111
yokoe@po.kyoundo.jp
NO
2018 | Year | 01 | Month | 12 | Day |
Partially published
No longer recruiting
2017 | Year | 10 | Month | 24 | Day |
2019 | Year | 03 | Month | 15 | Day |
2018 | Year | 01 | Month | 10 | Day |
2022 | Year | 03 | Month | 31 | Day |
All patients will be examined by contrast-enhanced CMR with cine MRI, tagging MRI on a 3.0 T MRI scanner. Multivariate analysis will be performed to assess the relationship between disease activities and biomarkers.
Using cine MRI and tagging MRI of 3.0 Tesla, we will analyze the relationship indicating myocardial disorder and the activity of RA. Since the 3.0 Tesla MRI is not available in our hospital, the examination will be performed at Yaesu clinic. During the observation period, the treatment of RA including the subscription of biological will be performed by the attending physician.
2018 | Year | 01 | Month | 05 | Day |
2021 | Year | 01 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034915
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |